Religion, Psychedelics, Risky Behavior, and Violence

References

• Abdaleati, N. S., N. M. Zaharim, and Y. O. Mydin. 2016. Religiousness and mental health: Systematic review study. Journal of Religion & Health 55 (6):1929–37. doi:10.1007/s10943-014-9896-1.
   PubMed Web of Science ®Google Scholar
• Acevedo, G. A., C. G. Ellison, and X. Xu. 2014. Is it really religion? Comparing the main and stress-buffering effects of religious and secular civic engagement on psychological distress. Society and Mental Health 4 (2):111–28. doi:10.1177/2156869313520558.
   Web of Science ®Google Scholar
• Almaraz, D., J. Saiz, F. Moreno Martín, I. Sánchez-Iglesias, A. J. Molina, and T. L. Goldsby. 2022. What aspects of religion and spirituality affect the physical health of cancer patients? A systematic review. Healthcare (Switzerland) 10 (8):1447. MDPI. doi:10.3390/healthcare10081447.
   PubMedGoogle Scholar
• Alonzo, D., and R. E. Gearing. 2021. Suicide across Buddhism, American Indian–Alaskan native, and African traditional religions, atheism and agnosticism: An updated systematic review. Journal of Religion and Health 60 (4):2527–46. doi:10.1007/s10943-021-01202-z.
   PubMed Web of Science ®Google Scholar
• Armstrong, R. A. 2014. When to use the Bonferroni correction. Ophthalmic and Physiological Optics 34 (5):502–08. doi:10.1111/opo.12131.
   PubMed Web of Science ®Google Scholar
• Bahr, S. J., S. L. Maughan, A. C. Marcos, and B. Li. 1998. Family, religiosity, and the risk of adolescent drug use. Journal of Marriage and the Family 60 (4):979. doi:10.2307/353639.
   Web of Science ®Google Scholar
• Barnett, B. S., K. Ziegler, R. Doblin, and A. D. Carlo. 2022. Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data. Journal of Psychopharmacology 36 (10):1118–28. doi:10.1177/02698811221117536.
   PubMed Web of Science ®Google Scholar
• Borges, C. C., P. R. dos Santos, P. M. Alves, R. C. M. Borges, G. Lucchetti, M. A. Barbosa, C. C. Porto, and M. R. Fernandes. 2021. Association between spirituality/religiousness and quality of life among healthy adults: A systematic review. Health and Quality of Life Outcomes 19(1). BioMed Central Ltd. doi:10.1186/s12955-021-01878-7.
   PubMed Web of Science ®Google Scholar
• Bradley, D. E. 1995. Religious involvement and social resources: Evidence from the data set “Americans” changing lives. Journal for the Scientific Study of Religion 34 (2):259–67. doi:10.2307/1386771.
   Web of Science ®Google Scholar
• Brewerton, T. D., J. B. Wang, A. Lafrance, C. Pamplin, M. Mithoefer, B. Yazar-Klosinki, A. Emerson, and R. Doblin. 2022. MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD. Journal of Psychiatric Research 149:128–35. doi:10.1016/j.jpsychires.2022.03.008.
   PubMed Web of Science ®Google Scholar
• Colorado General Assembly. 2023. Proposition 122: Decriminalization and Regulated Access Program for Certain Psychedelic Plants and Fungi Initiative. Denver, CO.
   Google Scholar
• Dar, I. A., and N. Iqbal. 2020. Beyond linear evidence: The curvilinear relationship between secondary traumatic stress and vicarious posttraumatic growth among healthcare professionals. Stress and Health 36 (2):203–12. doi:10.1002/smi.2932.
   PubMed Web of Science ®Google Scholar
• Davis, A. K., G. Agin-Liebes, M. España, B. Pilecki, and J. Luoma. 2021. Attitudes and beliefs about the therapeutic use of psychedelic drugs among psychologists in the United States. Journal of Psychoactive Drugs 54 (4):309–18. doi:10.1080/02791072.2021.1971343.
   PubMed Web of Science ®Google Scholar
• Davis, A. K., F. S. Barrett, D. G. May, M. P. Cosimano, N. D. Sepeda, M. W. Johnson, P. H. Finan, and R. R. Griffiths. 2021. Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry 78 (5):481–89. doi:10.1001/jamapsychiatry.2020.3285.
   PubMed Web of Science ®Google Scholar
• Davis, A. K., Y. Xin, N. D. Sepeda, A. Garcia-Romeu, and M. T. Williams. 2021. Increases in psychological flexibility mediate relationship between acute psychedelic effects and decreases in racial trauma symptoms among people of color. Chronic Stress 5:5. doi:10.1177/24705470211035607.
   Google Scholar
• de Oliveira Maraldi, E. 2020. Response bias in research on religion, spirituality and mental health: A critical review of the literature and methodological recommendations. Journal of Religion and Health 59 (2):772–83. doi:10.1007/s10943-018-0639-6.
   PubMed Web of Science ®Google Scholar
• dos Santos, R. G., J. C. Bouso, M. Á. Alcázar-Córcoles, and J. E. C. Hallak. 2018. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: A systematic review of systematic reviews. Expert Review of Clinical Pharmacology 11 (9):889–902. Taylor and Francis Ltd. doi:10.1080/17512433.2018.1511424.
   PubMed Web of Science ®Google Scholar
• Ellison, C. G., and A. K. Henderson. 2011. Religious and mental health: Through the lens of the stress process. In Toward a sociological theory of religion and health, ed. A. J. Blasi, 11–43. Boston, MA: Brill.
   Google Scholar
• Ferreira-Valente, A., S. Sharma, S. Torres, Z. Smothers, J. Pais-Ribeiro, J. H. Abbott, and M. P. Jensen. 2022. Does religiosity/spirituality play a role in function, pain-related beliefs, and coping in patients with chronic pain? A systematic review. Journal of Religion and Health 61 (3):2331–85. doi:10.1007/s10943-019-00914-7.
   PubMed Web of Science ®Google Scholar
• Fitchett, G., P. Murphy, J. Kim, J. L. Gibbons, J. R. Cameron, and J. A. Davis. 2004. Religious struggle: Prevalence, correlates and mental health risks in diabetic, congestive heart failure, and oncology patients. International Journal of Psychiatry in Medicine 34 (2):179–96. doi:10.2190/UCJ9-DP4M-9C0X-835M.
   PubMed Web of Science ®Google Scholar
• Gerber, M. M., A. Boals, and D. Schuettler. 2011. The unique contributions of positive and negative religious coping to posttraumatic growth and PTSD. Psychology of Religion and Spirituality 3 (4):298–307. doi:10.1037/a0023016.
   Web of Science ®Google Scholar
• Gillum, D. R., and C. L. Holt. 2010. Associations between religious involvement and behavioral risk factors for HIV/AIDS in American women and men in a national health survey. Annals of Behavioral Medicine 40 (3):284–93. doi:10.1007/s12160-010-9218-0.
   PubMed Web of Science ®Google Scholar
• Grant Weinandy, J. T., and J. B. Grubbs. 2021. Religious and spiritual beliefs and attitudes towards addiction and addiction treatment: A scoping review. Addictive Behaviors Reports 14:100393. doi:10.1016/j.abrep.2021.100393.
   PubMedGoogle Scholar
• Griffiths, R. R., M. W. Johnson, M. A. Carducci, A. Umbricht, W. A. Richards, B. D. Richards, M. P. Cosimano, and M. A. Klinedinst. 2016. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology 30 (12):1181–97. doi:10.1177/0269881116675513.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., W. A. Richards, U. McCann, and R. Jesse. 2006. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187 (3):268–83. doi:10.1007/s00213-006-0457-5.
   PubMed Web of Science ®Google Scholar
• Grim, B. J., and M. E. Grim. 2019. Belief, behavior, and belonging: How faith is indispensable in preventing and recovering from substance abuse. Journal of Religion and Health 58 (5):1713–50. doi:10.1007/s10943-019-00876-w.
   PubMed Web of Science ®Google Scholar
• Hadaway, C. K., K. W. Elifson, and D. M. Petersen. 1984. Religious involvement and drug use among urban adolescents. Journal for the Scientific Study of Religion 23 (2):109–28. doi:10.2307/1386103.
   Web of Science ®Google Scholar
• Hartogsohn, I. 2016. Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. Journal of Psychopharmacology 30 (12):1259–67. doi:10.1177/0269881116677852.
   PubMed Web of Science ®Google Scholar
• Hearld, K. R., A. Badham, and H. Budhwani. 2017. Statistical effects of religious participation and marriage on substance use and abuse in racial and ethnic minorities. Journal of Religion & Health 56 (4):1155–69. doi:10.1007/s10943-016-0330-8.
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., C. B. Clark, M. W. Johnson, K. R. Fontaine, and K. L. Cropsey. 2014. Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. Journal of Psychopharmacology 28 (1):62–66. doi:10.1177/0269881113513851.
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., M. S. Crawford, K. L. Cropsey, H. Copes, N. W. Sweat, Z. Walsh, and G. Pavela. 2018. The relationships of classic psychedelic use with criminal behavior in the United States adult population. Journal of Psychopharmacology 32 (1):37–48. doi:10.1177/0269881117735685.
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., C. B. Thorne, C. B. Clark, D. W. Coombs, and M. W. Johnson. 2015. Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology 29 (3):280–88. doi:10.1177/0269881114565653.
   PubMed Web of Science ®Google Scholar
• Hoffman, J. P., and S. M. Bahr. 2005. Crime/Deviance. In The handbook of religion and social institutions, ed. H. R. Ebaugh, 241–63. New York: Springer.
   Google Scholar
• Imran, M. H., Z. Zhai, and M. Iqbal. 2022. The role of religious coping to overcome mental distress and anxiety during the COVID-19 pandemic: An integrative review. Analyses of Social Issues and Public Policy 22 (3):817–35. doi:10.1111/asap.12327.
   Web of Science ®Google Scholar
• Istratii, R., and P. Ali. 2023. A scoping review on the role of religion in the experience of IPV and faith-based responses in community and counseling settings. Journal of Psychology and Theology 51 (2):141–73. doi:10.1177/00916471221143440.
   Web of Science ®Google Scholar
• Johnson, M. W., R. R. Griffiths, P. S. Hendricks, and J. E. Henningfield. 2018. The abuse potential of medical psilocybin according to the 8 factors of the controlled substances act. Neuropharmacology, the Neuropharmacology of Social Behavior: From Bench to Bedside 142:143–66. Elsevier Ltd. doi:10.1016/j.neuropharm.2018.05.012.
   Google Scholar
• Jones, G. M., and M. K. Nock. 2022. Mdma/Ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults. Journal of Psychopharmacology 36 (1):46–56. doi:10.1177/02698811211058923.
   PubMed Web of Science ®Google Scholar
• Koslowski, M., M. W. Johnson, G. Gründer, and F. Betzler. 2021. Novel treatment approaches for substance use disorders: Therapeutic use of psychedelics and the role of psychotherapy. Current Addiction Reports 9 (1):48–58. doi:10.1007/s40429-021-00401-8.
   Google Scholar
• Koss, M. P., J. A. Bailey, N. P. Yuan, V. M. Herrera, and E. L. Lichter. 2003. Depression and PTSD in survivors of male violence: Research and training initiatives to facilitate recovery. Psychology of Women Quarterly 27 (2):130–42. doi:10.1111/1471-6402.00093.
   Web of Science ®Google Scholar
• Krause, N. 2011. Stress, religious-bases coping, and phsyical health. In Toward a sociological theory of religion and health, ed. A. J. Blasi, 207–38. Boston, MA: Brill.
   Google Scholar
• Lamkin, M. 2021. Prescription psychedelics: The road from FDA approval to clinical practice. American Journal of Medicine 135 (1):15–16. doi:10.1016/j.amjmed.2021.07.033.
   PubMed Web of Science ®Google Scholar
• Lim, C., and R. D. Putnam. 2010. Religion, social networks, and life satisfaction. American Sociological Review 75 (6):914–33. doi:10.1177/0003122410386686.
   Web of Science ®Google Scholar
• Long, J. S., and J. Freese. 2014. Regression models for categorical dependent variables using Stata. 3rd ed. College Station, TX: Stata Press.
   Google Scholar
• Lucchetti, G., H. G. Koenig, and A. L. G. Lucchetti. 2021. Spirituality, religiousness, and mental health: A review of the current scientific evidence. World Journal of Clinical Cases 9 (26):7620–31. doi:10.12998/wjcc.v9.i26.7620.
   PubMed Web of Science ®Google Scholar
• Lund, P. 2017. Christian faith and recovery from substance abuse, guilt, and shame. Journal of Religion & Spirituality in Social Work 36 (3):346–66. doi:10.1080/15426432.2017.1302865.
   Web of Science ®Google Scholar
• Ly, C., A. C. Greb, L. P. Cameron, J. M. Wong, E. V. Barragan, P. C. Wilson, K. F. Burbach, S. Soltanzadeh Zarandi, A. Sood, M. R. Paddy, et al. 2018. Psychedelics promote structural and functional neural plasticity. Cell Reports 23 (11):3170–82. doi:10.1016/j.celrep.2018.05.022.
   PubMed Web of Science ®Google Scholar
• Maclean, K. A., M. W. Johnson, and R. R. Griffiths. 2011. Psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology 25 (11):1453–61. doi:10.1177/0269881111420188.
   PubMed Web of Science ®Google Scholar
• Magyar-Russell, G., I. T. Brown, I. R. Edara, M. T. Smith, J. E. Marine, and R. C. Ziegelstein. 2014. In search of serenity: Religious struggle among patients hospitalized for suspected acute coronary syndrome. Journal of Religion and Health 53 (2):562–78. doi:10.1007/s10943-013-9713-2.
   PubMed Web of Science ®Google Scholar
• Marks, M. 2023. The varieties of psychedelic law. Neuropharmacology, the Neuropharmacology of Social Behavior: From Bench to Bedside 226:109399. Elsevier Ltd. doi:10.1016/j.neuropharm.2022.109399.
   Google Scholar
• Martin, J. K., S. A. Tuch, and P. M. Roman. 2003. Problem drinking patterns among African Americans: The impacts of reports of discrimination, perceptions of prejudice, and “risky” coping strategies. Journal of Health and Social Behavior 44 (3):408–25. doi:10.2307/1519787.
   PubMed Web of Science ®Google Scholar
• McCullough, M. E., and B. L. B. Willoughby. 2009. Religion, self-regulation, and self-control: Associations, explanations, and implications. Psychological Bulletin 135 (1):69–93. doi:10.1037/a0014213.
   PubMed Web of Science ®Google Scholar
• Mellner, C., M. Dahlen, and O. Simonsson. 2022. Association between lifetime classic psychedelic use and sick leave in a population-based sample. International Journal of Environmental Research and Public Health 19 (18):11353. 19(18. doi:10.3390/ijerph191811353.
   PubMed Web of Science ®Google Scholar
• Mithoefer, M. C., A. A. Feduccia, L. Jerome, A. Mithoefer, M. Wagner, Z. Walsh, S. Hamilton, B. Yazar-Klosinski, A. Emerson, and R. Doblin. 2019. MDMA-assisted psychotherapy for treatment of PTSD: Study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology 236 (9):2735–45. doi:10.1007/s00213-019-05249-5.
   PubMed Web of Science ®Google Scholar
• Neitzke-Spruill, L. 2019. Race as a component of set and setting: How experiences of race can influence psychedelic experiences. Journal of Psychedelic Studies 4 (1):51–60. doi:10.1556/2054.2019.022.
   Google Scholar
• NIH. 2021. Marijuana use at historic high among college-aged adults in 2020.
   Google Scholar
• Noorani, T. 2021. Containment matters: Set and setting in contemporary psychedelic psychiatry. Philosophy, Psychiatry, & Psychology 28 (3):201–16. doi:10.1353/ppp.2021.0032.
   Web of Science ®Google Scholar
• Ollove, M. 2022. More states may legalize psychedelic mushrooms. Stateline, July 15. https://stateline.org/2022/07/15/more-states-may-legalize-psychedelic-mushrooms/.
   Google Scholar
• Pargament, K. I., and J. J. Exline. 2020. Religious and spiritual struggles. https://www.telegraph.co.uk/global-health/climate-and-people/pandemic-prompts-surge-interest-prayer-google-data-
   Google Scholar
• Pargament, K. I., M. Feuille, and D. Burdzy. 2011. The brief RCOPE: Current psychometric status of a short measure of religious coping. Religions 2 (4):51–76. doi:10.3390/rel2010051.
   Web of Science ®Google Scholar
• Pargament, K. I., B. W. Smith, H. G. Koenig, and L. M. Perez. 1998. Patterns of positive and negative religious coping with major life stressors. Journal for the Scientific Study of Religion 37 (4):710–24. doi:10.2307/1388152.
   Web of Science ®Google Scholar
• Peck, R. 2021. The psychedelic renaissance: A convergence of indigenous knowledge and science. Portland State University. doi:10.15760/honors.1171.
   Google Scholar
• Penn, A., C. G. Dorsen, S. Hope, and W. E. Rosa. 2021. Psychedelic-assisted therapy: Emerging treatments in mental health disorders. American Journal of Nursing 121 (6):34–40. doi:10.1097/01.naj.0000753464.35523.29.
   PubMedGoogle Scholar
• Pomerleau, J. M., K. I. Pargament, N. Krause, G. Ironson, and P. Hill. 2020. Religious and spiritual struggles as a mediator of the link between stressful life events and psychological adjustment in a nationwide sample. Psychology of Religion and Spirituality 12 (4):451–59. doi:10.1037/rel0000268.
   Web of Science ®Google Scholar
• Richard, A. J., D. C. Bell, and J. W. Carlson. 2000. Individual religiosity, moral community, and drug user treatment. Journal for the Scientific Study of Religion 39 (2):240–46. doi:10.1111/0021-8294.00019.
   Web of Science ®Google Scholar
• Rodríguez Arce, J. M., and M. J. Winkelman. 2021. Psychedelics, sociality, and human evolution. Frontiers in Psychology 12 (September):1–26. doi:10.3389/fpsyg.2021.729425.
   Google Scholar
• Roseman, L., D. J. Nutt, and R. L. Carhart-Harris. 2018. Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in Pharmacology 8 (JAN):1–10. doi:10.3389/fphar.2017.00974.
   Google Scholar
• Sanz-Barbero, B., C. Linares, C. Vives-Cases, J. L. González, J. J. López-Ossorio, and J. Díaz. 2018. Heat wave and the risk of intimate partner violence. Science of the Total Environment 644:413–19. doi:10.1016/j.scitotenv.2018.06.368.
   PubMed Web of Science ®Google Scholar
• Schnabel, L., and S. Bock. 2017. The persistent and exceptional intensity of American religion: A response to recent research. Sociological Science 4:686–700. doi:10.15195/v4.a28.
   Web of Science ®Google Scholar
• Sexton, J. D., M. S. Crawford, N. W. Sweat, A. Varley, E. E. Green, and P. S. Hendricks. 2019. Prevalence and epidemiological associates of novel psychedelic use in the United States adult population. Journal of Psychopharmacology 33 (9):1058–67. doi:10.1177/0269881119827796.
   PubMed Web of Science ®Google Scholar
• Simonsson, O., P. S. Hendricks, R. Carhart-Harris, H. Kettner, and W. Osika. 2021. Association between lifetime classic psychedelic use and hypertension in the past Year. Hypertension 77 (5):1510–16. doi:10.1161/HYPERTENSIONAHA.120.16715.
   PubMed Web of Science ®Google Scholar
• Simonsson, O., P. S. Hendricks, R. Chambers, W. Osika, and S. B. Goldberg. 2022. Classic psychedelics, health behavior, and physical health. Therapeutic Advances in Psychopharmacology 12:204512532211353. doi:10.1177/20451253221135363.
   Web of Science ®Google Scholar
• Simonsson, O., W. Osika, R. Carhart-Harris, and P. S. Hendricks. 2021. Associations between lifetime classic psychedelic use and cardiometabolic diseases. Scientific Reports 11 (1):10–14. doi:10.1038/s41598-021-93787-4.
   PubMed Web of Science ®Google Scholar
• Simonsson, O., J. D. Sexton, and P. S. Hendricks. 2021. Associations between lifetime classic psychedelic use and markers of physical health. Journal of Psychopharmacology 35 (4):447–52. doi:10.1177/0269881121996863.
   PubMed Web of Science ®Google Scholar
• Szabo, A. 2015. Psychedelics and immunomodulation: Novel approaches and therapeutic opportunities. Frontiers in Immunology 6 (JUN):1–11. doi:10.3389/fimmu.2015.00358.
   PubMedGoogle Scholar
• Vanderweele, T. J. 2017. Religion and health: A synthesis. In Spirituality and religion within the culture of medicine: From evidence to practice, ed. M. Balboni and J. Peteet, 357–401. New York, NY: Oxford University Press.
   Google Scholar
• Viña, S. M. 2024a. Diminished psychedelic returns on distress: Marital status and household size. Public Library of Science ONE 19 (Forthcoming):1–23. doi:10.1371/journal.pone.0293675.
   Google Scholar
• Viña, S. M. 2024b. Minorities’ diminished psychedelic returns: Cardio-Metabolic Health. Drug Science, Policy and Law 10:1–13. doi:10.1177/20503245231225756.
   Google Scholar
• Viña, S. M. 2024c. Navigating psychedelic policy. Contexts 23 (1):58–59. doi:10.1177/15365042241229715.
   Google Scholar
• Viña, S. M., and A. L. Stephens. 2023a. Minorities’ diminished psychedelic returns. Drug Science, Policy and Law 9:1–19. doi:10.1177/20503245231184638.
   Google Scholar
• Viña, S. M., and A. L. Stephens. 2023b. Psychedelics and workplace harm. Frontiers in Psychiatry 14 (JUNE):1–9. doi:10.3389/fpsyt.2023.1186541.
   Google Scholar
• Wallace, J. M., Jr., and T. A. Forman. 1998. Religion’s role in promoting health and reducing risk among American youth. Health Education and Behavior 25 (6):721–41. doi:10.1177/109019819802500604.
   PubMed Web of Science ®Google Scholar
• Walsh, Z., P. S. Hendricks, S. Smith, D. S. Kosson, M. S. Thiessen, P. Lucas, and M. T. Swogger. 2016. Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use. Journal of Psychopharmacology 30 (7):601–07. doi:10.1177/0269881116642538.
   PubMed Web of Science ®Google Scholar
• Weber, M. C., and S. E. Schulenberg. 2023. The curvilinear relationships between posttraumatic growth and posttraumatic stress, depression, and anxiety. Traumatology 29 (2):249–60. doi:10.1037/trm0000398.
   Google Scholar
• Yaden, D. B., A. P. Berghella, P. S. Regier, A. Garcia-Romeu, M. W. Johnson, and P. S. Hendricks. 2021. Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs. International Journal of Drug Policy 98:103380. doi:10.1016/j.drugpo.2021.103380.
   PubMed Web of Science ®Google Scholar
• Zeifman, R. J., N. Singhal, L. Breslow, and C. R. Weissman. 2021. On the relationship between classic psychedelics and suicidality: A systematic review. ACS Pharmacology and Translational Science 4 (2):436–51. American Chemical Society. doi:10.1021/acsptsci.1c00024.
   PubMedGoogle Scholar
• Zenic, N., M. Stipic, and D. Sekulic. 2013. Religiousness as a factor of hesitation against doping behavior in college-age athletes. Journal of Religion & Health 52 (2):386–96. doi:10.1007/s10943-011-9480-x.
   PubMed Web of Science ®Google Scholar
• Zhong, S., R. Yu, and S. Fazel. 2020. Drug use disorders and violence: Associations with individual drug categories. Epidemiologic Reviews 42 (1):103–16. Oxford University Press. doi:10.1093/epirev/mxaa006.
   PubMed Web of Science ®Google Scholar